Docoh
Loading...

BRKR Bruker

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Company profile

Ticker
BRKR
Exchange
Website
CEO
Frank Laukien
Employees
Incorporated
Location
Fiscal year end
Former names
BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC
SEC CIK
Subsidiaries
Research Instruments GmbH • Bruker AXS GmbH • Bruker Mexicana S.A de C.V. • InCoaTec GmbH • Bruker BioSpin MRI GmbH • Bruker Invest AG • Bruker AXS Ltd. • Bruker-Physik GmbH • Bruker BioSpin GmbH • Bruker Daltonik GmbH ...
IRS number
43110160

BRKR stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

5 Nov 21
2 Dec 21
31 Dec 21
Quarter (USD)
Sep 21 Jun 21 Mar 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Bruker earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 576.5M 576.5M 576.5M 576.5M 576.5M 576.5M
Cash burn (monthly) 11.73M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 24.52M n/a n/a n/a n/a n/a
Cash remaining 551.98M n/a n/a n/a n/a n/a
Runway (months of cash) 47.0 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
24 Nov 21 Marc A Kastner Common Stock Sell Dispose S No No 76.86 10,000 768.6K 11,146
24 Nov 21 Marc A Kastner Common Stock Option exercise Acquire M No No 19.9 10,000 199K 21,146
24 Nov 21 Marc A Kastner Stock Option (Right to Purchase) Common Stock Option exercise Dispose M No No 19.9 10,000 199K 0
2 Nov 21 William A Linton Common Stock Option exercise Acquire M No No 12.77 6,000 76.62K 9,237
2 Nov 21 William A Linton Stock Option (Right to Purchase) Common Stock Option exercise Dispose M No No 12.77 6,000 76.62K 0
2 Sep 21 Juergen Srega Common Stock Sell Dispose S No No 89.5397 202,216 18.11M 130,936
2 Sep 21 Juergen Srega Common Stock Option exercise Acquire M No No 22.19 39,468 875.79K 333,152
2 Sep 21 Juergen Srega Common Stock Option exercise Acquire M No No 19.82 35,438 702.38K 293,684
2 Sep 21 Juergen Srega Common Stock Option exercise Acquire M No No 20.68 25,369 524.63K 258,246
2 Sep 21 Juergen Srega Common Stock Option exercise Acquire M No No 18.57 90,000 1.67M 232,877

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

68.4% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 292 277 +5.4%
Opened positions 50 59 -15.3%
Closed positions 35 26 +34.6%
Increased positions 115 96 +19.8%
Reduced positions 85 85
13F shares
Current Prev Q Change
Total value 8.37B 8.16B +2.5%
Total shares 103.68M 104.4M -0.7%
Total puts 10.5K 38.1K -72.4%
Total calls 184.4K 104.2K +77.0%
Total put/call ratio 0.1 0.4 -84.4%
Largest owners
Shares Value Change
TROW T. Rowe Price 23.96M $1.87B -3.7%
FMR 16.38M $1.28B -18.9%
Vanguard 10.5M $819.91M -0.9%
BLK Blackrock 6.51M $508.2M -0.1%
Alliancebernstein 3.29M $257M +11.0%
STT State Street 2.08M $162.33M +1.4%
Acadian Asset Management 2.08M $162.11M +26.5%
Fuller & Thaler Asset Management 2.02M $158.11M +8.6%
Arrowstreet Capital, Limited Partnership 1.96M $153M +29.9%
IVZ Invesco 1.87M $145.84M -8.5%
Largest transactions
Shares Bought/sold Change
FMR 16.38M -3.81M -18.9%
TROW T. Rowe Price 23.96M -926.59K -3.7%
Two Sigma Advisers 698.5K +676.3K +3046.4%
Millennium Management 308.67K -614.42K -66.6%
Ceredex Value Advisors 809.98K +589.17K +266.8%
Massachusetts Financial Services 1.62M +583.91K +56.2%
AMP Ameriprise Financial 0 -556.88K EXIT
Arrowstreet Capital, Limited Partnership 1.96M +451.15K +29.9%
Acadian Asset Management 2.08M +434.87K +26.5%
GS Goldman Sachs 824.3K +433.37K +110.9%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: attrition, Biden, certainty, coating, covering, difficulty, directed, display, easily, eds, exact, handle, labor, manner, MRI, NaN, Nanosegment, ne, November, OSHA, PCI, resolving, robust, SCI, stable, storage, system, thecompany, transmitted, unsuccessful, weekly
Removed: affiliated, cut, delay, PCR, prevailing, unfavorable

Patents

GRANT
Utility
MAS probehead with a thermally insulated sample chamber
30 Nov 21
An MAS probehead (1) positioned in a magnet bore (2) includes a sample chamber (3) with a stator (4) for receiving a rotor and an RF coil that radiates RF pulses into and/or receives RF signals from an NMR sample (5).
GRANT
Utility
Method for determining motion states of at least two bodies and method for simultaneously imaging at least two bodies
9 Nov 21
Techniques for determining motion states of at least two bodies by an MR-device are provided, wherein the bodies each have a respective target region which is in an anatomic motion comprising a repetitive motion pattern with a motion repetition rate, and in particular, for cardiac and/or respiratory motion.
GRANT
Utility
Hybrid MPI and MRI/CT imaging apparatus and method
9 Nov 21
A hybrid imaging apparatus for imaging an object to be examined located in a sample volume can be operated in an MPI mode and in at least one further imaging mode and comprises a magnet arrangement embodied to generate, in the MPI mode, a magnetic field with a gradient B1 and a field-free region in the sample volume, wherein the magnet arrangement comprises a ring magnet pair with two ring magnets in a Halbach dipole configuration, which are arranged coaxially on a common Z-axis that extends through the sample volume, wherein the ring magnets are arranged so as to be twistable relative to one another about the Z-axis.
APP
Utility
Processing of Spatially Resolved, Ion-spectrometric Measurement Signal Data to Determine Molecular Content Scores In Two-dimensional Samples
28 Oct 21
The invention relates to methods for processing ion-spectrometric measurement signal data which are recorded spatially resolved across a two-dimensional sample, comprising: —providing the measurement signal data which have a plurality of measurement signal histograms, where a histogram contains a measurement signal tuple with intensity dimension (J), mass dimension (m), and collision cross-section dimension (σ), or quantities derived therefrom; —specifying first and second selections of ionic species for the sample, whose presence in histograms is detectable and distinguishable using the collision cross-section dimension or proxy; —determining the spatially resolved content of ionic species from the first and second selections in histograms of the finite areas (Afin,x,y), and computing the various contents to form spatially resolved content scores (Gx,y); and —labeling the sample with the content scores (Gx,y).
GRANT
Utility
Mass spectrometric resistance determination by measuring metabolism
12 Oct 21
The invention relates to a mass spectrometric method to determine microbial resistances to antibiotics.